🟢 HCW Biologics is trading 9.4% up in pre-market as catalyst remains unclear

HCW Biologics is trading 9.4% up at $1.28 in pre-market; the reason for the move is unclear.

• No new company-specific announcement for October 21 was identified in the available search.
• The latest release found was October 9, about FDA guidance and continued preparation for an IND filing targeted for the first half of 2027; it does not establish a direct reason for the move.
• Broader market indicators were mixed-to-positive, but available evidence does not tie them to the move.